Program Definition
A multi-disciplinary translational R&D program dedicated to reverse-engineering, mapping, engineering, and clinically deploying blood-derived extracellular vesicle systems for:
- Immune regulation
- Regenerative medicine
- Precision diagnostics
- Blood replacement technologies
- Organ communication engineering
- Cell-free therapeutics
- Synthetic biological communication systems
PROGRAM STRUCTURE
DIVISION I
HEMOREGEN-IMMUNO
Blood EV Immunology Platform
Focus:
Immune synapse communication and adaptive immune programming.
Deliverable HEM-IMM-001
APC-to-T Cell EV Priming Atlas
Program Code:
HEMOREGEN-IMM-001
Former Code:
SCF-VIRA-EVCM-0004A
Purpose:
Map APC-derived EV instruction systems responsible for:
- T-cell priming
- Clonal expansion
- Differentiation
- Memory formation
Primary Applications:
- Cancer vaccines
- Infectious disease vaccines
- Personalized immunotherapy
Deliverable HEM-IMM-002
Treg EV Tolerance Architecture
Program Code:
HEMOREGEN-IMM-002
Former Code:
SCF-VIRA-EVCM-0004B
Purpose:
Map immune tolerance communication networks.
Primary Applications:
- Autoimmune disease
- Organ transplantation
- Allergy desensitization
Deliverable HEM-IMM-003
NK/CTL Cytotoxic EV Blueprint
Purpose:
Map cytotoxic EV-mediated target elimination.
Applications:
- Oncology
- Viral infection
- Cellular immunotherapy
Deliverable HEM-IMM-004
Tumor Immune-Escape EV Atlas
Purpose:
Reverse-engineer tumor-derived immune suppressive EV systems.
Applications:
- Immune checkpoint engineering
- Cancer diagnostics
- Metastasis prevention
Deliverable HEM-IMM-005
Viral Exhaustion EV Loop Map
Purpose:
Characterize chronic immune exhaustion signaling.
Applications:
- Chronic viral infections
- Long COVID research
- Immunorestorative therapies
DIVISION II
HEMOREGEN-COMM
Blood EV Communication Systems
Focus:
Whole-body biological intelligence networks.
Deliverable HEM-COMM-001
Blood EV Cargo Mapping Framework
Former Code:
SCF-VIRA-EVCM-0001
Purpose:
Master catalog of blood EV cargo systems.
Deliverable HEM-COMM-002
Blood EV Address Code Atlas
Former Code:
SCF-VIRA-EVCM-0002
Purpose:
Map EV targeting and routing mechanisms.
Deliverable HEM-COMM-003
Organ-to-Organ EV Communication Network
Former Code:
SCF-VIRA-EVCM-0003
Purpose:
Construct a whole-body communication connectome.
Applications:
- Systems biology
- Multi-organ disease modeling
- Digital twin medicine
Deliverable HEM-COMM-004
Human Organ Communication Connectome
Purpose:
Comprehensive network graph of EV-mediated organ communication.
Applications:
- Precision medicine
- AI disease simulation
- Organ failure prediction
Deliverable HEM-COMM-005
Whole-Body EV Network Simulation Engine
Purpose:
Computational simulation platform.
Applications:
- Drug testing
- Network perturbation modeling
- Disease forecasting
DIVISION III
HEMOREGEN-DX
EV Diagnostics Platform
Focus:
Blood EV biomarkers.
Deliverable HEM-DX-001
EV Biomarker Reference Atlas
Applications:
- Oncology
- Autoimmunity
- Neurodegeneration
- Cardiovascular disease
Deliverable HEM-DX-002
EV Liquid Biopsy Platform
Applications:
- Cancer screening
- Treatment monitoring
- Minimal residual disease detection
Deliverable HEM-DX-003
EV Communication Failure Atlas
Applications:
- Early disease detection
- Predictive medicine
DIVISION IV
HEMOREGEN-RX
EV Therapeutic Engineering Platform
Focus:
Cell-free biologic medicines.
Deliverable HEM-RX-001
Engineered APC-EV Vaccine Platform
Applications:
- Cancer
- Infectious disease
Deliverable HEM-RX-002
Tolerogenic EV Therapeutics Platform
Applications:
- Autoimmune disease
- Transplant medicine
Deliverable HEM-RX-003
Cytotoxic EV Oncology Platform
Applications:
- Solid tumors
- Hematologic malignancies
Deliverable HEM-RX-004
Regenerative EV Therapeutics Platform
Applications:
- Tissue repair
- Fibrosis reversal
- Organ regeneration
Deliverable HEM-RX-005
Synthetic Programmable EV Platform
Applications:
- Precision drug delivery
- RNA therapeutics
- Gene editing payloads
DIVISION V
HEMOREGEN-BLOOD
Blood Replacement and Regeneration Platform
Focus:
Blood-derived EV technologies for transfusion medicine.
Deliverable HEM-BLD-001
Blood EV Quality Monitoring System
Applications:
- Blood banking
- Transfusion optimization
Deliverable HEM-BLD-002
EV-Augmented Blood Preservation Platform
Applications:
- Extended storage
- Reduced storage lesion
Deliverable HEM-BLD-003
Universal Blood EV Engineering Platform
Applications:
- Compatibility enhancement
- Immune modulation
Deliverable HEM-BLD-004
Synthetic Hemoregulatory EV Platform
Applications:
- Trauma medicine
- Military medicine
- Disaster medicine
PROJECT HEMOREGEN-721 CLINICAL DEVELOPMENT PATHWAY
Phase H1
Foundational Mapping
- Cargo atlas
- Address atlas
- Communication network atlas
Phase H2
Mechanistic Validation
- In vitro models
- Organoid systems
- Human blood datasets
Phase H3
Therapeutic Engineering
- Vaccine EVs
- Tolerance EVs
- Cytotoxic EVs
- Regenerative EVs
Phase H4
Translational Biomarker Development
- Companion diagnostics
- Liquid biopsy systems
Phase H5
Clinical Development
Aligned with IND/NDA/BLA pathways described in FDA development frameworks.
MASTER PROGRAM REGISTRY
HEMOREGEN-721-PROG-0001 — Project HEMOREGEN-721 Master Program
HEMOREGEN-IMM-001 — APC-to-T Cell EV Priming Atlas
HEMOREGEN-IMM-002 — Treg EV Tolerance Architecture
HEMOREGEN-IMM-003 — NK/CTL Cytotoxic EV Blueprint
HEMOREGEN-IMM-004 — Tumor Immune-Escape EV Atlas
HEMOREGEN-IMM-005 — Viral Exhaustion EV Loop Map
HEMOREGEN-COMM-001 — Blood EV Cargo Mapping Framework
HEMOREGEN-COMM-002 — Blood EV Address Code Atlas
HEMOREGEN-COMM-003 — Organ-to-Organ EV Communication Network
HEMOREGEN-COMM-004 — Human Organ Communication Connectome
HEMOREGEN-COMM-005 — Whole-Body EV Network Simulation Engine
HEMOREGEN-DX-001 — EV Biomarker Reference Atlas
HEMOREGEN-RX-001 — Engineered APC-EV Vaccine Platform
HEMOREGEN-RX-002 — Tolerogenic EV Therapeutics Platform
HEMOREGEN-RX-003 — Cytotoxic EV Oncology Platform
HEMOREGEN-RX-004 — Regenerative EV Therapeutics Platform
HEMOREGEN-RX-005 — Synthetic Programmable EV Platform
HEMOREGEN-BLD-001 — Blood EV Quality Monitoring System
HEMOREGEN-BLD-002 — EV-Augmented Blood Preservation Platform
HEMOREGEN-BLD-003 — Universal Blood EV Engineering Platform
HEMOREGEN-BLD-004 — Synthetic Hemoregulatory EV Platform